annual EBITDA:
-$2.14B-$1.49B(-227.12%)Summary
- As of today (May 29, 2025), BIO annual EBITDA is -$2.14 billion, with the most recent change of -$1.49 billion (-227.12%) on December 31, 2024.
- During the last 3 years, BIO annual EBITDA has fallen by -$7.73 billion (-138.33%).
- BIO annual EBITDA is now -138.33% below its all-time high of $5.59 billion, reached on December 31, 2021.
Performance
BIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$133.50M+$991.03M(+115.57%)Summary
- As of today (May 29, 2025), BIO quarterly EBITDA is $133.50 million, with the most recent change of +$991.03 million (+115.57%) on March 31, 2025.
- Over the past year, BIO quarterly EBITDA has dropped by -$407.00 million (-75.30%).
- BIO quarterly EBITDA is now -97.36% below its all-time high of $5.06 billion, reached on September 30, 2021.
Performance
BIO quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$2.55B-$407.00M(-19.00%)Summary
- As of today (May 29, 2025), BIO TTM EBITDA is -$2.55 billion, with the most recent change of -$407.00 million (-19.00%) on March 31, 2025.
- Over the past year, BIO TTM EBITDA has dropped by -$2.30 billion (-931.69%).
- BIO TTM EBITDA is now -129.27% below its all-time high of $8.71 billion, reached on September 30, 2021.
Performance
BIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -227.1% | -75.3% | -931.7% |
| 3 y3 years | -138.3% | +103.1% | -3421.7% |
| 5 y5 years | -188.6% | -85.8% | -216.4% |
BIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -138.3% | +52.7% | -88.3% | +103.1% | <-9999.0% | +66.7% |
| 5 y | 5-year | -138.3% | +52.7% | -97.4% | +103.1% | -129.3% | +66.7% |
| alltime | all time | -138.3% | +52.7% | -97.4% | +103.1% | -129.3% | +66.7% |
BIO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $133.50M(-115.6%) | -$2.55B(+19.0%) |
| Dec 2024 | -$2.14B(+227.1%) | -$857.53M(-194.0%) | -$2.14B(+165.6%) |
| Sep 2024 | - | $912.69M(-133.3%) | -$806.50M(-47.4%) |
| Jun 2024 | - | -$2.74B(-606.5%) | -$1.53B(+520.2%) |
| Mar 2024 | - | $540.50M(+13.1%) | -$247.07M(-62.3%) |
| Dec 2023 | -$654.80M(-85.5%) | $477.92M(+155.8%) | -$654.80M(<-9900.0%) |
| Sep 2023 | - | $186.80M(-112.9%) | $5.81M(-101.7%) |
| Jun 2023 | - | -$1.45B(-1193.9%) | -$342.35M(+423.1%) |
| Mar 2023 | - | $132.77M(-88.3%) | -$65.45M(-98.6%) |
| Dec 2022 | -$4.53B(-181.0%) | $1.14B(-805.6%) | -$4.53B(-40.9%) |
| Sep 2022 | - | -$161.35M(-86.3%) | -$7.66B(+214.0%) |
| Jun 2022 | - | -$1.18B(-72.9%) | -$2.44B(+3269.2%) |
| Mar 2022 | - | -$4.33B(+117.7%) | -$72.38M(-101.3%) |
| Dec 2021 | $5.59B(+10.0%) | -$1.99B(-139.3%) | $5.59B(-35.8%) |
| Sep 2021 | - | $5.06B(+324.6%) | $8.71B(+62.0%) |
| Jun 2021 | - | $1.19B(-10.5%) | $5.38B(-1.7%) |
| Mar 2021 | - | $1.33B(+17.7%) | $5.47B(+7.7%) |
| Dec 2020 | $5.08B(+110.0%) | $1.13B(-34.4%) | $5.08B(+8.3%) |
| Sep 2020 | - | $1.72B(+34.0%) | $4.69B(+75.7%) |
| Jun 2020 | - | $1.29B(+37.1%) | $2.67B(+21.8%) |
| Mar 2020 | - | $937.99M(+26.8%) | $2.19B(-9.4%) |
| Dec 2019 | $2.42B(+258.5%) | $739.89M(-350.0%) | $2.42B(+256.6%) |
| Sep 2019 | - | -$295.99M(-136.6%) | $678.20M(-50.3%) |
| Jun 2019 | - | $808.64M(-30.7%) | $1.37B(+45.7%) |
| Mar 2019 | - | $1.17B(-216.5%) | $937.10M(+38.9%) |
| Dec 2018 | $674.72M(+150.3%) | -$1.00B(-355.8%) | $674.72M(-61.9%) |
| Sep 2018 | - | $391.10M(+2.8%) | $1.77B(+22.0%) |
| Jun 2018 | - | $380.46M(-57.9%) | $1.45B(+30.2%) |
| Mar 2018 | - | $903.77M(+857.1%) | $1.11B(+313.4%) |
| Dec 2017 | $269.52M(+29.7%) | $94.43M(+31.6%) | $269.52M(+44.8%) |
| Sep 2017 | - | $71.76M(+62.5%) | $186.18M(+2.7%) |
| Jun 2017 | - | $44.16M(-25.4%) | $181.23M(-12.5%) |
| Mar 2017 | - | $59.16M(+433.4%) | $207.14M(-0.3%) |
| Dec 2016 | $207.84M(-30.6%) | $11.09M(-83.4%) | $207.84M(-28.5%) |
| Sep 2016 | - | $66.81M(-4.7%) | $290.81M(+0.7%) |
| Jun 2016 | - | $70.07M(+17.1%) | $288.80M(-2.2%) |
| Mar 2016 | - | $59.87M(-36.4%) | $295.23M(-1.4%) |
| Dec 2015 | $299.34M(-1.4%) | $94.06M(+45.2%) | $299.34M(+1.2%) |
| Sep 2015 | - | $64.80M(-15.3%) | $295.79M(-0.8%) |
| Jun 2015 | - | $76.50M(+19.6%) | $298.30M(-4.5%) |
| Mar 2015 | - | $63.98M(-29.3%) | $312.50M(+2.9%) |
| Dec 2014 | $303.59M(-5.4%) | $90.52M(+34.5%) | $303.59M(-1.0%) |
| Sep 2014 | - | $67.31M(-25.8%) | $306.62M(+1.3%) |
| Jun 2014 | - | $90.70M(+64.7%) | $302.68M(-1.6%) |
| Mar 2014 | - | $55.07M(-41.1%) | $307.61M(-4.1%) |
| Dec 2013 | $320.86M(-22.0%) | $93.55M(+47.6%) | $320.86M(-4.4%) |
| Sep 2013 | - | $63.37M(-33.7%) | $335.60M(-9.6%) |
| Jun 2013 | - | $95.63M(+40.0%) | $371.27M(-3.7%) |
| Mar 2013 | - | $68.31M(-36.9%) | $385.71M(-5.4%) |
| Dec 2012 | $411.42M(-2.0%) | $108.29M(+9.3%) | $407.87M(-4.8%) |
| Sep 2012 | - | $99.04M(-10.0%) | $428.44M(+0.1%) |
| Jun 2012 | - | $110.07M(+21.7%) | $427.90M(+2.5%) |
| Mar 2012 | - | $90.47M(-29.8%) | $417.31M(-0.6%) |
| Dec 2011 | $419.98M(+6.9%) | $128.85M(+30.8%) | $419.98M(+5.6%) |
| Sep 2011 | - | $98.50M(-1.0%) | $397.81M(-0.0%) |
| Jun 2011 | - | $99.49M(+6.8%) | $397.95M(+0.9%) |
| Mar 2011 | - | $93.14M(-12.7%) | $394.23M(+0.3%) |
| Dec 2010 | $392.90M(+17.4%) | $106.69M(+8.2%) | $392.90M(+6.1%) |
| Sep 2010 | - | $98.64M(+3.0%) | $370.37M(+1.8%) |
| Jun 2010 | - | $95.76M(+4.3%) | $363.67M(+3.0%) |
| Mar 2010 | - | $91.81M(+9.1%) | $352.99M(+5.5%) |
| Dec 2009 | $334.56M(+23.0%) | $84.15M(-8.5%) | $334.56M(+17.3%) |
| Sep 2009 | - | $91.94M(+8.1%) | $285.23M(+5.7%) |
| Jun 2009 | - | $85.08M(+15.9%) | $269.90M(-1.6%) |
| Mar 2009 | - | $73.38M(+110.7%) | $274.36M(+0.8%) |
| Dec 2008 | $272.06M(+78.5%) | $34.82M(-54.6%) | $272.06M(-2.0%) |
| Sep 2008 | - | $76.63M(-14.4%) | $277.62M(+9.7%) |
| Jun 2008 | - | $89.53M(+26.0%) | $253.09M(+18.4%) |
| Mar 2008 | - | $71.08M(+76.0%) | $213.71M(+9.1%) |
| Dec 2007 | $152.45M(-33.6%) | $40.39M(-22.5%) | $195.85M(-12.6%) |
| Sep 2007 | - | $52.09M(+3.9%) | $224.17M(+3.9%) |
| Jun 2007 | - | $50.15M(-5.8%) | $215.80M(-2.9%) |
| Mar 2007 | - | $53.23M(-22.5%) | $222.34M(-3.1%) |
| Dec 2006 | $229.45M(+30.1%) | $68.71M(+57.2%) | $229.45M(+15.3%) |
| Sep 2006 | - | $43.72M(-22.9%) | $199.05M(+2.0%) |
| Jun 2006 | - | $56.69M(-6.0%) | $195.23M(+7.6%) |
| Mar 2006 | - | $60.34M(+57.5%) | $181.38M(+2.9%) |
| Dec 2005 | $176.30M(-1.5%) | $38.31M(-4.0%) | $176.30M(-3.3%) |
| Sep 2005 | - | $39.89M(-6.9%) | $182.38M(-0.0%) |
| Jun 2005 | - | $42.84M(-22.5%) | $182.39M(-1.9%) |
| Mar 2005 | - | $55.26M(+24.5%) | $185.85M(+3.8%) |
| Dec 2004 | $178.97M | $44.39M(+11.3%) | $178.97M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2004 | - | $39.90M(-13.8%) | $178.23M(-2.5%) |
| Jun 2004 | - | $46.30M(-4.3%) | $182.74M(-0.2%) |
| Mar 2004 | - | $48.37M(+10.8%) | $183.17M(-3.0%) |
| Dec 2003 | $189.43M(+37.1%) | $43.66M(-1.7%) | $188.85M(+5.3%) |
| Sep 2003 | - | $44.41M(-4.9%) | $179.41M(-0.7%) |
| Jun 2003 | - | $46.72M(-13.6%) | $180.72M(+3.0%) |
| Mar 2003 | - | $54.06M(+58.0%) | $175.50M(+5.9%) |
| Dec 2002 | $138.19M(-9.9%) | $34.22M(-25.1%) | $165.70M(-6.1%) |
| Sep 2002 | - | $45.72M(+10.1%) | $176.54M(+9.1%) |
| Jun 2002 | - | $41.51M(-6.2%) | $161.82M(+3.1%) |
| Mar 2002 | - | $44.26M(-1.8%) | $156.96M(-4.1%) |
| Dec 2001 | $153.33M(+39.3%) | $45.06M(+45.3%) | $163.63M(+13.4%) |
| Sep 2001 | - | $31.00M(-15.4%) | $144.35M(+3.6%) |
| Jun 2001 | - | $36.64M(-28.0%) | $139.29M(+5.6%) |
| Mar 2001 | - | $50.93M(+97.5%) | $131.94M(+9.3%) |
| Dec 2000 | $110.08M(+44.7%) | $25.78M(-0.6%) | $120.76M(+2.2%) |
| Sep 2000 | - | $25.94M(-11.4%) | $118.17M(+12.5%) |
| Jun 2000 | - | $29.29M(-26.3%) | $105.03M(+11.9%) |
| Mar 2000 | - | $39.75M(+71.4%) | $93.84M(+23.4%) |
| Dec 1999 | $76.09M(+46.0%) | $23.19M(+81.2%) | $76.03M(+12.7%) |
| Sep 1999 | - | $12.80M(-29.3%) | $67.45M(+8.5%) |
| Jun 1999 | - | $18.09M(-17.5%) | $62.15M(+11.1%) |
| Mar 1999 | - | $21.94M(+50.1%) | $55.96M(+7.2%) |
| Dec 1998 | $52.12M(+13.1%) | $14.62M(+94.9%) | $52.22M(+6.4%) |
| Sep 1998 | - | $7.50M(-37.0%) | $49.10M(-1.0%) |
| Jun 1998 | - | $11.90M(-34.6%) | $49.60M(0.0%) |
| Mar 1998 | - | $18.20M(+58.3%) | $49.60M(+7.1%) |
| Dec 1997 | $46.10M(-19.0%) | $11.50M(+43.8%) | $46.30M(-1.1%) |
| Sep 1997 | - | $8.00M(-32.8%) | $46.80M(-10.0%) |
| Jun 1997 | - | $11.90M(-20.1%) | $52.00M(-3.7%) |
| Mar 1997 | - | $14.90M(+24.2%) | $54.00M(-5.6%) |
| Dec 1996 | $56.90M(+0.9%) | $12.00M(-9.1%) | $57.20M(-3.5%) |
| Sep 1996 | - | $13.20M(-5.0%) | $59.30M(+1.9%) |
| Jun 1996 | - | $13.90M(-23.2%) | $58.20M(+1.2%) |
| Mar 1996 | - | $18.10M(+28.4%) | $57.50M(+2.1%) |
| Dec 1995 | $56.40M(+5.4%) | $14.10M(+16.5%) | $56.30M(+1.1%) |
| Sep 1995 | - | $12.10M(-8.3%) | $55.70M(+1.3%) |
| Jun 1995 | - | $13.20M(-21.9%) | $55.00M(+0.4%) |
| Mar 1995 | - | $16.90M(+25.2%) | $54.80M(+2.4%) |
| Dec 1994 | $53.50M(+98.1%) | $13.50M(+18.4%) | $53.50M(+18.6%) |
| Sep 1994 | - | $11.40M(-12.3%) | $45.10M(+13.0%) |
| Jun 1994 | - | $13.00M(-16.7%) | $39.90M(+17.4%) |
| Mar 1994 | - | $15.60M(+205.9%) | $34.00M(+26.4%) |
| Dec 1993 | $27.00M(-4.9%) | $5.10M(-17.7%) | $26.90M(-10.9%) |
| Sep 1993 | - | $6.20M(-12.7%) | $30.20M(-2.6%) |
| Jun 1993 | - | $7.10M(-16.5%) | $31.00M(+29.7%) |
| Mar 1993 | - | $8.50M(+1.2%) | $23.90M(-16.1%) |
| Dec 1992 | $28.40M(-17.0%) | $8.40M(+20.0%) | $28.50M(+3.3%) |
| Sep 1992 | - | $7.00M(>+9900.0%) | $27.60M(-4.2%) |
| Jun 1992 | - | $0.00(-100.0%) | $28.80M(-20.9%) |
| Mar 1992 | - | $13.10M(+74.7%) | $36.40M(+6.4%) |
| Dec 1991 | $34.20M(-1.4%) | $7.50M(-8.5%) | $34.20M(-9.0%) |
| Sep 1991 | - | $8.20M(+7.9%) | $37.60M(+3.9%) |
| Jun 1991 | - | $7.60M(-30.3%) | $36.20M(0.0%) |
| Mar 1991 | - | $10.90M(0.0%) | $36.20M(+4.3%) |
| Dec 1990 | $34.70M(+19.7%) | $10.90M(+60.3%) | $34.70M(+13.8%) |
| Sep 1990 | - | $6.80M(-10.5%) | $30.50M(+3.4%) |
| Jun 1990 | - | $7.60M(-19.1%) | $29.50M(-0.7%) |
| Mar 1990 | - | $9.40M(+40.3%) | $29.70M(-61.2%) |
| Dec 1989 | $29.00M(+10.7%) | $6.70M(+15.5%) | $76.60M(-237.0%) |
| Sep 1989 | - | $5.80M(-25.6%) | -$55.90M(+260.6%) |
| Jun 1989 | - | $7.80M(-86.1%) | -$15.50M(-160.3%) |
| Mar 1989 | - | $56.30M(-144.8%) | $25.70M(+29.1%) |
| Dec 1988 | $26.20M(+21.9%) | -$125.80M(-372.3%) | $19.90M(-57.4%) |
| Sep 1988 | - | $46.20M(-5.7%) | $46.70M(+18.2%) |
| Jun 1988 | - | $49.00M(-3.0%) | $39.50M(+34.4%) |
| Mar 1988 | - | $50.50M(-151.0%) | $29.40M(+79.3%) |
| Dec 1987 | $21.50M(+41.4%) | -$99.00M(-353.8%) | $16.40M(-52.7%) |
| Sep 1987 | - | $39.00M(+0.3%) | $34.70M(+29.5%) |
| Jun 1987 | - | $38.90M(+3.7%) | $26.80M(+38.9%) |
| Mar 1987 | - | $37.50M(-146.5%) | $19.30M(+63.6%) |
| Dec 1986 | $15.20M(+42.1%) | -$80.70M(-359.5%) | $11.80M(-54.8%) |
| Sep 1986 | - | $31.10M(-1.0%) | $26.10M(+27.9%) |
| Jun 1986 | - | $31.40M(+4.7%) | $20.40M(+47.8%) |
| Mar 1986 | - | $30.00M(-145.2%) | $13.80M(+60.5%) |
| Dec 1985 | $10.70M(+91.1%) | -$66.40M(-361.4%) | $8.60M(-51.1%) |
| Sep 1985 | - | $25.40M(+2.4%) | $17.60M(+43.1%) |
| Jun 1985 | - | $24.80M(0.0%) | $12.30M(+55.7%) |
| Mar 1985 | - | $24.80M(-143.2%) | $7.90M(+119.4%) |
| Dec 1984 | $5.60M | -$57.40M(-385.6%) | $3.60M(-94.1%) |
| Sep 1984 | - | $20.10M(-1.5%) | $61.00M(+49.1%) |
| Jun 1984 | - | $20.40M(-0.5%) | $40.90M(+99.5%) |
| Mar 1984 | - | $20.50M | $20.50M |
FAQ
- What is Bio-Rad Laboratories annual EBITDA?
- What is the all time high annual EBITDA for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual EBITDA year-on-year change?
- What is Bio-Rad Laboratories quarterly EBITDA?
- What is the all time high quarterly EBITDA for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly EBITDA year-on-year change?
- What is Bio-Rad Laboratories TTM EBITDA?
- What is the all time high TTM EBITDA for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM EBITDA year-on-year change?
What is Bio-Rad Laboratories annual EBITDA?
The current annual EBITDA of BIO is -$2.14B
What is the all time high annual EBITDA for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual EBITDA is $5.59B
What is Bio-Rad Laboratories annual EBITDA year-on-year change?
Over the past year, BIO annual EBITDA has changed by -$1.49B (-227.12%)
What is Bio-Rad Laboratories quarterly EBITDA?
The current quarterly EBITDA of BIO is $133.50M
What is the all time high quarterly EBITDA for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly EBITDA is $5.06B
What is Bio-Rad Laboratories quarterly EBITDA year-on-year change?
Over the past year, BIO quarterly EBITDA has changed by -$407.00M (-75.30%)
What is Bio-Rad Laboratories TTM EBITDA?
The current TTM EBITDA of BIO is -$2.55B
What is the all time high TTM EBITDA for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM EBITDA is $8.71B
What is Bio-Rad Laboratories TTM EBITDA year-on-year change?
Over the past year, BIO TTM EBITDA has changed by -$2.30B (-931.69%)